Solving the most complex challenges, together
Let’s uncover your lab’s full potential
Your hospital lab plays a central role in delivering accurate diagnoses and patient-centric treatment plans. It’s a hub that supports your providers with critical data and actionable results. What if there were ways to improve its performance — with optimized utilization and even revenue generation? It’s more than possible, and we’re here to help.
Strategies for enhancing lab performance
With the need to cut costs while delivering quality care, hospital leaders are under pressure like never before. Your own in-house lab can support both goals. Our e-book provides key strategies for maximizing the value of your lab — by eliminating inappropriate test utilization, building revenue opportunities though outreach programs, and more. Discover the details by sharing your information below.
Download the “Finding Value in the Hospital Lab” e-book now.
Numbers that make a difference
It all adds up to better business and better care.
3,500+
specialty tests and pathology services to augment local hospital lab offerings
600+
successful outreach engagements nationwide to drive revenue
12%
average cost reduction by identifying unnecessary genetic tests
24/7
support from Mayo Clinic physicians and scientists
Eliminate financial waste. Increase accuracy.
Over and underutilization of your lab is inefficient and costly. We’ll help you optimize utilization with expertly designed diagnostic testing algorithms for more accurate ordering and results.
Expand capabilities. Establish leadership.
Extending your services through an outreach program can provide a significant revenue stream, increasing test volumes and lowering per-unit costs without straining lab capacity. This can mean successfully competing against commercial labs and serving as your local area’s indispensable go-to lab.
Do more. For patients and providers.
When you strengthen your practice, you position your lab as a center of excellence. And with our ongoing reference lab support, we can take on your more esoteric tests for better patient diagnosis and care, and provide expert peer-to-peer consults for your providers. We’ll help you do more for all those you serve.
Our collaborations in action
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the right diagnosis for patients.
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as multiple myeloma. Based on recently published data, the new testing algorithms focus on use of fluorescence in situ hybridization (FISH) panels, rather than chromosome studies.
Mayo Clinic’s Biochemical Genetics Laboratory has announced an updated second-tier test to detect Krabbe disease (KD) that uses psychosine (PSY) as a disease marker. The new test method has significantly higher sensitivity to detect this devastating disease in infants and allows identification of KD patients with minimal psychosine elevations.